Capecitabine (Capecitabine Cipla, Capeloda)
Capecitabine
Cipla Medpro (Pty) Ltd
Registration
- Applicant
- Cipla Medpro (Pty) Ltd
- Registrations
- 4
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Capecitabine cipla 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg | 150 | 47036147/26/0361 | Cancelled | S4 | None |
| Capecitabine cipla 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg | 500 | 47036247/26/0362 | Cancelled | S4 | None |
| Capeloda 150 EACH TABLET CONTAINS CAPECITABINE 150,0 mg | 150 / 500 mgFilm-coated tablets | 47036347/26/0363Approved 26 June 2019 | Registered | S4 | PIPIL |
| Capeloda 500 EACH TABLET CONTAINS CAPECITABINE 500,0 mg | 150 / 500 mgFilm-coated tablets | 47036447/26/0364Approved 26 June 2019 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Capecitabine
S4: Capecitabine
Consolidated Schedules 06 July 2026, line 5647
Pharmacological class: Cytostatic agents (class 26)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
Drag to rotate. Structure from PubChem CID 60953.
SAHPRA documents
Schedule Verification
This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.